Peter I. Lobo

4.1k total citations
84 papers, 3.3k citations indexed

About

Peter I. Lobo is a scholar working on Immunology, Transplantation and Surgery. According to data from OpenAlex, Peter I. Lobo has authored 84 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 27 papers in Transplantation and 12 papers in Surgery. Recurrent topics in Peter I. Lobo's work include Renal Transplantation Outcomes and Treatments (26 papers), Immune Cell Function and Interaction (23 papers) and T-cell and B-cell Immunology (23 papers). Peter I. Lobo is often cited by papers focused on Renal Transplantation Outcomes and Treatments (26 papers), Immune Cell Function and Interaction (23 papers) and T-cell and B-cell Immunology (23 papers). Peter I. Lobo collaborates with scholars based in United States, France and Saudi Arabia. Peter I. Lobo's co-authors include David A. Horwitz, Mark D. Okusa, Liping Huang, Li L, Frederic B. Westervelt, Sun‐Sang J. Sung, Diane L. Rosin, Ross B. Isaacs, William Stevenson and Sultan T. Al‐Sedairy and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Peter I. Lobo

83 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter I. Lobo United States 29 1.4k 605 563 550 473 84 3.3k
Ulrich Kunzendorf Germany 36 1.6k 1.2× 681 1.1× 665 1.2× 2.4k 4.3× 961 2.0× 118 5.6k
Josette Eris Australia 29 812 0.6× 1.5k 2.5× 1.1k 2.0× 621 1.1× 474 1.0× 56 3.6k
Wolfgang Steurer Austria 26 702 0.5× 764 1.3× 1.1k 2.0× 376 0.7× 204 0.4× 98 2.9k
Liliane Schandené Belgium 35 2.0k 1.4× 126 0.2× 995 1.8× 443 0.8× 80 0.2× 96 4.2k
Mandy L. Ford United States 39 2.7k 2.0× 918 1.5× 1.1k 2.0× 911 1.7× 85 0.2× 179 4.9k
William Dameshek United States 44 1.1k 0.8× 204 0.3× 609 1.1× 728 1.3× 230 0.5× 166 5.5k
Marie‐Josée Hébert Canada 32 530 0.4× 540 0.9× 528 0.9× 901 1.6× 362 0.8× 89 3.0k
Alaín Le Moine Belgium 34 2.4k 1.7× 524 0.9× 570 1.0× 648 1.2× 87 0.2× 101 3.9k
Ching‐Yuang Lin Taiwan 34 721 0.5× 60 0.1× 690 1.2× 714 1.3× 665 1.4× 174 4.0k
André Herbelin France 43 3.9k 2.8× 70 0.1× 950 1.7× 583 1.1× 919 1.9× 108 6.1k

Countries citing papers authored by Peter I. Lobo

Since Specialization
Citations

This map shows the geographic impact of Peter I. Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter I. Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter I. Lobo more than expected).

Fields of papers citing papers by Peter I. Lobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter I. Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter I. Lobo. The network helps show where Peter I. Lobo may publish in the future.

Co-authorship network of co-authors of Peter I. Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of Peter I. Lobo. A scholar is included among the top collaborators of Peter I. Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter I. Lobo. Peter I. Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lobo, Peter I. & Mark D. Okusa. (2019). Role of Natural IgM and IgM Induced Bregs in Preventing Ischemia Induced Innate Inflammation and Acute Kidney Injury. ˜The œNephron journals/Nephron journals. 143(3). 166–169. 5 indexed citations
2.
Lobo, Peter I.. (2017). Role of Natural IgM Autoantibodies (IgM-NAA) and IgM Anti-Leukocyte Antibodies (IgM-ALA) in Regulating Inflammation. Current topics in microbiology and immunology. 408. 89–117. 14 indexed citations
3.
Lobo, Peter I.. (2016). Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Frontiers in Immunology. 7. 198–198. 79 indexed citations
4.
Turza, Kristin C., Michael Shafique, Peter I. Lobo, et al.. (2014). Infectious Complications in Living-Donor Kidney Transplant Recipients Undergoing Multi-Modal Desensitization. Surgical Infections. 15(3). 182–186. 1 indexed citations
5.
Lobo, Peter I., Kenneth L. Brayman, & Mark D. Okusa. (2014). Natural IgM Anti-leucocyte Autoantibodies (IgM-ALA) Regulate Inflammation Induced by Innate and Adaptive Immune Mechanisms. Journal of Clinical Immunology. 34(S1). 22–29. 15 indexed citations
6.
Kinsey, Gilbert R., Liping Huang, Katarzyna Jaworska, et al.. (2012). Autocrine Adenosine Signaling Promotes Regulatory T Cell–Mediated Renal Protection. Journal of the American Society of Nephrology. 23(9). 1528–1537. 122 indexed citations
7.
L, Li, Liping Huang, Hong Ye, et al.. (2012). Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. Journal of Clinical Investigation. 122(11). 3931–3942. 128 indexed citations
8.
Chhabra, Preeti, et al.. (2012). Naturally Occurring Immunoglobulin M (nIgM) Autoantibodies Prevent Autoimmune Diabetes and Mitigate Inflammation After Transplantation. Annals of Surgery. 256(4). 634–641. 18 indexed citations
9.
L, Li, Liping Huang, Sun‐Sang J. Sung, et al.. (2007). NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury. The Journal of Immunology. 178(9). 5899–5911. 267 indexed citations
10.
Haq, Afrozul, et al.. (1999). Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. International Journal of Immunopharmacology. 21(4). 283–295. 139 indexed citations
11.
Sanfey, Hilary, et al.. (1997). Steroid withdrawal in kidney transplant recipients: is it a safe option?. Clinical Transplantation. 11(5pt2). 500–504. 11 indexed citations
12.
Stevenson, William, et al.. (1996). Need for reduction of cyclosporin dosage in renal transplant patients with hypertriglyceridemia but not hypercholesterolemia. Transplant International. 9(2). 164–167. 3 indexed citations
15.
Haq, Afrozul, et al.. (1995). Nigella sativa: effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity. Immunopharmacology. 30(2). 147–155. 120 indexed citations
16.
Lobo, Peter I., et al.. (1995). The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch. Transplant International. 8(6). 472–480. 31 indexed citations
19.
Sturgill, Benjamin C., Peter I. Lobo, & W. Kline Bolton. (1984). Cold-Reacting IgM Antibody-Induced Renal Allograft Failure. ˜The œNephron journals/Nephron journals. 36(2). 125–127. 10 indexed citations
20.
Lobo, Peter I., et al.. (1977). Enhanced kidney allograft survival across a positive crossmatch (Cx) arising from B-cell specific and cold reactive antibodies (Ab).. PubMed. 7. 4–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026